Project Grant R03TR005428
Award Date
7/1/24
Completion Date
6/30/25
Dollars Obligated
$177K
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
The National Institutes of Health, through the National Center for Advancing Translational Sciences (CFDA 93.350), awarded a $163,750 Project Grant to The Johns Hopkins University to develop a human keratinocyte model and test the efficacy of lentiviral-mediated SPCA1 delivery for treating Hailey Hailey disease. The grant supports two specific aims: 1) clarifying the disease mechanism underlying the rare autosomal dominant skin disorder caused by ATP2C1 gene mutations, and 2) evaluating the...
This Project Grant award of $161,922 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at The Johns Hopkins University to investigate the role of gamma secretase (GS) activity and nicastrin (NCSTN) regulation in hidradenitis suppurativa (HS), a chronic inflammatory skin condition. The research aims to define the enzymatic activity of GS and regulation of NCSTN expression in HS fibroblasts, as well as...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $343,904 to The Regents of the University of California, San Francisco to investigate transcriptional abnormalities in skin-resident T cells as potential biomarkers for atopic dermatitis in Asian and Hispanic genetic backgrounds. The research aims to validate an abnormal atopic T...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $359,879 to the University of North Carolina at Chapel Hill to conduct research on the genetic basis of hidradenitis suppurativa (HS), a chronic inflammatory skin disease. The research aims to build upon previous genome-wide association studies to identify additional genetic risk...
This federal Project Grant award of $466,198, awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research into the role of cortisol synthesis in the pathogenesis of intradermal tunnels associated with hidradenitis suppurativa (HS), a common and debilitating inflammatory skin disease. The key products and services to be delivered under this grant include:...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is focused on elucidating the mechanisms underlying the pathogenesis of Hao-Fountain Syndrome, a rare genetic disease caused by USP7 variants. The $456,892 award, effective from August 1, 2025 to July 31, 2027, will support research to investigate the effect of Hao-Fountain Syndrome variants on the ERK1/2...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research Federal Grant Program (CFDA 93.846), will enable Duke University to develop a 3D skin model system to investigate interactions between the skin microbiome and skin cell populations. The $198,782 award, effective April 10, 2025 through March 31, 2027, will fund the creation of 3D reconstructed human epidermis (RHE)...
This $178,000 Project Grant award from the National Center for Advancing Translational Sciences (NCATS), under CFDA 93.350, supports research to better understand the localization and function of the SLC24A5 gene and its role in skin pigmentation. The grantee, The Children's Hospital of Philadelphia (CHOP), will generate a panel of mouse melanocyte cell lines to investigate the subcellular localization of the NCKX5 protein encoded by SLC24A5, and assess the impact of SLC24A5 mutations on...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $461,528 to the University of Connecticut Health Center (UCHC) to create the first human-based cellular model of Hao-Fountain syndrome. The goal is to understand the effect of disease-linked mutations on the enzymatic function of USP7 and on neuron differentiation and morphology....
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is focused on defining and treating genetic abnormalities in psoriasis/atopic dermatitis-overlap dermatoses. The total award amount is $628,968.00 with a project period from June 20, 2025 to April 30, 2030. The awardee is The Regents of the University of California, San Francisco (UCSF), a prominent...